Bioarctic Ab

BioArctic AB, a Stockholm-based biopharma focusing on CNS disorders, leverages proprietary antibody platform to develop phase‑3 candidates for Alzheimer’s and Parkinson’s, with collaborations with Eisai and AbbVie.

Headquarters: Sweden (SWE)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Hospitals

Employees: 122
HQ: Stockholm

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
BIOA-B	Bioarctic Ab Cap: 27.7B \| P/E: 27.7	EQUITY	STO	SEK	SE0010323311	Active	📈